Furthermore, decreased endocan levels have been described for sepsis patients that developed progression of inflammation to acute respiratory distress syndrome, and the most severe cytokine release syndrome during COVID-19 infection is associated with lower endocan levels than moderate inflammatory disease [83]. This evidence concerns the gene ESM1 and Sepsis.